What We Offer
Buy-Side Advisory
Helping Investors and Operators Acquire With Confidence
We work closely with strategic buyers and healthcare investors to identify, evaluate, and acquire pharmacies across Canada. With a hands-on approach and real-time sourcing strategies, we connect you with deals that align with your growth thesis, whether you're pursuing a roll-up or making your first acquisition.
What’s included:
Targeted deal sourcing based on criteria
Preliminary screening and financial analysis
Coordination of diligence, negotiation, and closing
Strategic market insights and advisory support
Sell Side Representation
Supporting Pharmacy Owners Through a Successful Exit
Selling a pharmacy is a major decision, and we’re here to make sure you do it with confidence. We partner with owners to guide them through the full sale process: from initial valuation and preparation, to buyer outreach, deal structuring, and closing. Our approach is personalized, discreet, and built around your goals.
What’s included:
Business valuation and financial review
Confidential marketing to qualified buyers
Management of offers, negotiations, and due diligence
Deal structuring and closing support
Transition planning and post-sale guidance
Valuations & Strategy
Clarity Before the Deal
Whether you’re preparing to sell, thinking about succession, or exploring market expansion, our advisory services provide the clarity you need to make the right call. We apply financial rigor and industry context to give you a clear picture of where your business stands and where it can go.
What’s included:
Independent business valuation
Financial modeling and earnings normalization
Benchmarking against market comps
Strategic options analysis
Pre-transaction readiness planning
Frequently Asked Questions
-
We are a specialized M&A advisory firm dedicated to the pharmacy sector. We provide end-to-end transaction support, including confidential valuations, strategic buyer sourcing, and full-cycle deal execution for both acquisitions and divestitures.
-
A standard transaction cycle generally spans 3 to 6 months. This timeline is influenced by the complexity of the deal, the readiness of financial documentation, and the duration of the due diligence and regulatory approval phases.
-
To conduct a rigorous valuation, we typically require the last three years of financial statements, three years of plan summary reports, and detailed generic sales reports. We provide a comprehensive checklist once a non-disclosure agreement (NDA) is in place.
-
Absolutely. Many owners engage us to understand their market position and explore strategic options. A confidential valuation is a prudent first step in long-term succession planning.
-
We maintain a vetted network of qualified buyers, ranging from independent pharmacists and regional chains to private equity-backed healthcare groups. Every prospect is pre-screened for financial capacity and strategic fit.
-
Yes. Transition structures vary; many buyers value the continuity of the founding owner remaining in an advisory or operational capacity for a set period. We negotiate these transition agreements to align with your personal and professional goals.
-
You maintain full control of the process. There is no obligation to proceed with a transaction unless the terms, including valuation, structure, and legacy, meet your specific requirements.
-
Yes. We partner with individual pharmacists and corporate groups to identify acquisition targets that align with their growth objectives, providing support through due diligence, financial modeling, and closing.
-
For transactions facilitated by our firm, our fees are structured as a success fee paid by the purchasing party. This model ensures that selling pharmacy owners can access our expert advisory services without any upfront cost.
Let’s Talk.
Thinking of selling your pharmacy? Or interested in developing an acquisition strategy? We can help you determine your next step.